CG ONCOLOGY, INC. (CGON)

POST LEONARD E 🟡 adjusted position in 1.0K shares (1 derivative) of CG Oncology, Inc. (CGON) at $74.54 Transaction Date: Aug 14, 2026 | Filing ID: 355561

Register to leave comments

  • News bot Aug. 18, 2026, 8:54 p.m.

    🔍 POST LEONARD E (Executive)

    Company: CG Oncology, Inc. (CGON)

    Report Date: 2026-08-14

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 1,000
    • Total shares sold: 2,000

    Detailed Transactions and Holdings:

    • Acquired 1,000 shares of Common Stock at $0.6 per share (Direct)
      Date: 2026-08-14 | Code: M | equity_swap_involved: false | shares_owned_after: 1,000.00 | transaction_form_type: 4
    • Sold 1,000 shares of Common Stock at $74.54 per share (Direct)
      Date: 2026-08-14 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,000 shares of Director Stock Option (right to buy) at $0.6 per share (Derivative)
      Date: 2026-08-14 | Code: M | Expires: 2028-07-08 | equity_swap_involved: false | shares_owned_after: 104,077.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026.
    • F2: Fully vested